We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CYTO market cap is 408.92k. The company's latest EPS is CHF -11.0701 and P/E is -0.27.
| Quarter End | Mar 2014 | ||||
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 0 | ||||
| Operating Income | -5.86M | ||||
| Net Income | -5.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 0 | 0 | 64k | 306k | 158k |
| Operating Income | -7.26M | -5.5M | -17.1M | -26.13M | -7.73M |
| Net Income | -6.63M | -8.2M | -17.39M | -26.53M | -3.87M |
| Quarter End | Mar 2014 | ||||
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 20.86M | ||||
| Total Liabilities | 3.99M | ||||
| Total Equity | 16.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 9.23M | 20.8M | 18.84M | 6.3M | 7.69M |
| Total Liabilities | 3.19M | 4.03M | 6.13M | 14.62M | 1.24M |
| Total Equity | 6.04M | 16.77M | 12.71M | -8.32M | 6.46M |
| Quarter End | Mar 2014 | ||||
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -5.19M | ||||
| Investing | -57k | ||||
| Financing | -87k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -8.39M | -4.84M | -13.67M | -8.68M | -11.51M |
| Investing | -3M | -2.32M | -3.51M | -2.14M | 1.45M |
| Financing | 7.38M | 16.96M | 6.61M | 9.83M | 10.62M |
| Market Cap | 408.92k |
| Price to Earnings Ratio | -0.27 |
| Price to Sales Ratio | 6.72 |
| Price to Cash Ratio | 1.72 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 349.5k |
| Average Volume (1 week) | 68.58k |
| Average Volume (1 Month) | 3.02M |
| 52 Week Change | -92.29% |
| 52 Week High | 17.20 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.09 (7.2%) |
| Company Name | Altamira Therapeutics Ltd |
| Address |
dornacherstrasse 210 basel 4053 |
| Website | https://altamiratherapeutics.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
